Biotechnology, one of molecular biology’s branches, monitored and intentional manipulation of biological organisms, processes or systems to effectively make or process drugs, or any other products and substances useful to enhancing people’s living quality. The earliest examples of humans applying their knowledge of biotechnology involved the efforts to enhance plants and animals’ species by cross-pollination (allogamy) or cross-breeding.
Biotechnology has recently turned to a more sophisticated business, considerably enlarged in scale and application range. Having goodly restored from the recession, the world Biotechnology Market is anticipated to be eventually estimated at far over EUR 245 billion by end-2015. However, with the numerous benefits this advanced technology comes laden with, there are worries about its potential misuse. Concerns over this issue has trailed into some attempting to facilitate the enforcement of specific laws constraining or even banning relevant programs and research (e.g. human cloning).
The research reports from this Catalogue offer a comprehensive outlook on the worldwide Biotechnology Market. The reports identify major market challenging forces and growth drivers, provide fresh statistics on the Biotechnology Industry, outline various trends and factors specifying the market’s direction, and more. Regional and country markets’ reviews are at hand in the reports too. Furthermore, companies with their innovations are discussed, and also short to long term forecasts are provided in the researches.
Publications found:
1,310
Sort by:
China Biopharmaceuticals Mfg. Industry Profile - CIC2760
US$ 580.00
... investment environment in top 10 hot regions. In addition, the report truly reflects the position of foreign enterprises in biopharmaceuticals mfg. industry across China based on a comprehensive comparison of operating conditions among different enterprise types. This report includes the data for the year ...
May 2013
28 pages
Competitor Analysis: Therapeutic Proteins – Biosimilars, Biobetters & Biosuperiors
US$ 2,100.00
The new Competitive Intelligence Report Therapeutic Proteins – Biosimilars, Biobetters & Biosuperiors of May 2013 provides a competitor analysis in the product portfolios and development pipelines of ten major classes of therapeutic proteins and their biosimilar and biobetter/biosuperior versions in regulated ...
May 2013
301 pages
Biosimilars And Follow-On Biologics: World Market 2013-2023
US$ 2,635.00
... other aspects of the field, including these: Developments in technology to aid biosimilar production Incidence and prevalence of diseases affecting demand for the ... those substitutes, helping you stay ahead. Nine ways Biosimilars and Follow-On Biologics: World Market 2013-2023 helps you In particular, then ...
April 2013
235 pages
Cell Culture: The Market for Media, Sera and Reagents, 5th Edition
US$ 3,995.00
... currently employed and emerging in the cell culture area, Kalorama's exhaustive report provides specific information on: Market Size, growth, and forecasts ... Discussion of the preferences in media types vying for dominance in the market, including the following: ADCF - animal derived component free media ...
April 2013
152 pages
India Stem Cell Banking Market Analysis
US$ 500.00
... in the stem cell banking market of India. “India Stem Cell Banking Market Analysis” research report outlines following aspects related to booming stem cell banking in India: India Stem Cell Research & Therapy Market Overview Stem Cell Banking Market Overview Cord Blood & Menstrual Banking Cost Analysis ...
April 2013
55 pages
Biobanking For Medicine: Technology And Market 2013-2023
US$ 2,635.00
... -temperature storage Energy conservation in biorepositories Consumables, RFID and tagging technologies Automated storage and retrieval systems for operational efficiency Software ... its prospects, helping you stay ahead. Eight ways Biobanking for Medicine: Technology and Market 2013-2023 helps you To sum ...
March 2013
158 pages
Antibody Technologies and Attrition Rates - an Industry Analysis 2013
US$ 2,765.00
... legal literature. The report provides descriptive statistics of the 504 naked antibodies and their status during the study period of January 1, 2013 to ... the different in vitro and in antibody generation technologies. Attrition rate was defined as the percentage of failed antibodies of all active and inactive ...
March 2013
607 pages
Next-Generation Antibody Therapeutics Market 2013-2023
US$ 2,635.00
... (mAbs) and other immunotechnology. See forecasted sales at overall world market and submarket level. Also assess emerging trends and expected ... technological and commercial possibilities. Eight ways Next-Generation Antibody Therapeutics Market 2013-2023 helps In particular, then, our investigation gives ...
February 2013
164 pages
Therapeutic Class Report Overview - Rituxan Biosimilar
US$ 2,000.00
The growth in the biosimilar opportunity will be driven by several patent expiries of mega-blockbuster biologics in the next 5 years. Between 2012 and 2017, over $60b worth of sales of biologics in the US/EU will lose patent protection. Out of them, Roche’s/Biogen Idec’s Rituxan/MabThera (rituximab), Merck ...
February 2013
45 pages
Latin American Markets for Dental Bone Graft Substitutes and Other Biomaterials
US$ 7,995.00
... membranes is expected to grow at a CAGR of 17.1% by 2019. The total Latin American dental market for bone graft substitute and other biomaterials increased ... segment and prepares an unbiased critical assessment of such market drivers and limiters based on our “bottom up” approach, which includes primary and ...
January 2013
162 pages
Therapeutic Class Report Overview - Japan Biosimilars
US$ 1,000.00
... forces as compared to generics, a number of companies aim to exploit this – Japan has seen a flood like consolidation and partnering activities in biosimilar ... , Yoshindo etc. to be amongst the key players in biogenerics business in Japan. In this piece, we attempt to evaluate the future competitive landscape of ...
January 2013
32 pages
Global Transfection (Gene Delivery, DNA Delivery, Protein Delivery, SiRNA Delivery) Technologies (Lipofection, Calcium Phosphate, Electroporation, Nucleofection, Magnetofection, Gene Gun, Viral) Market (2012 – 2017)
US$ 5,650.00
... cell lines, gene therapy, delivery of therapeutics and also drug discovery. This research report provides a brief description on transfection technologies, its ... Roche, Polyplus Transfection, Mirius Bio, Maxcyte, etc. SCOPE OF THE REPORT A comprehensive analysis of the market size and global revenue has ...
December 2012
130 pages
Indian Stem Cell Banking Market: Trends & Opportunities (2012-2017)
US$ 700.00
... rates of stem cell banking ranging from 15% to 30%. Regions such as, US, Europe, China and India have low penetration ... stem cells from embryos. The report titled ‘Indian Stem Cell Banking Market: Trend and Opportunities (2012-2017)’ provides an in-depth analysis of the Indian stem cell banking market ...
November 2012
54 pages
Innovative Hematology and Flow Cytometry Technologies and Emerging Markets
US$ 22,720.00
... potential market entrants identify and evaluate emerging opportunities in the hematology and flow cytometry markets during the next ten years. The ... forces regulating systemic diseases, will have a profound impact on the hematology and flow cytometry markets worldwide. New molecular diagnostic and monoclonal ...
November 2012
700 pages
China Biological & Biochemical Products Market Report
US$ 680.00
... and number of employees, the report shows their market positions in China. Additionally, this report lists basic contact information of the top ... the structure and concentration ratio of the current biological & biochemical products market in China by means of Bain's Market Structure Classification and Index ...
October 2012
50 pages
Risk – Reward of Developing a Herceptin Biosimilar – A Thorough Assessment
US$ 2,000.00
... barriers that Biosimilar players should be aware. The report – “Risk – Reward of Developing a Herceptin biosimilar – A thorough assessment” looks into several aspects of potential ... their impact on Market Opportunity Global Regulatory Process and Hurdles Risk/Reward profile of developing Herceptin biosimilar
October 2012
70 pages
The Biometrics Market 2012-2022
US$ 2,943.00
... all highlighting strategic business opportunities. Why you should buy Biometrics Market 2012-2022 217 pages of comprehensive analysis 137 tables, charts, and graphs 3 Interviews with leading Biometrics companies: Cross Match Technologies DigitalPersona Inc. BIO-key Global Biometrics ...
September 2012
217 pages
Future Horizons in the European Hematology and Flow Cytometry Markets--France, Germany, Italy, Spain, UK: Supplier Shares and Sales Forecasts for 40 Tests by Country
US$ 14,800.00
... hematology and flow cytometry markets during the next five years. The report explores future marketing and technological trends in five major European countries (France, Germany, Italy, Spain, UK); provides market share estimates, test volume forecasts, and instrument placements; compares features of leading ...
September 2012
450 pages
World Biomass Report Ed 1, 2011
US$ 1,445.00
... often transported at great distance, rather than wood chips or other less dense biomass sources. In the wood pellets market, supplies from the US and Canada ... counterparts and thus North America is a major suppli- ers for European biomass plants. CIS countries, Russia, Australia and South Africa have entered ...
September 2012
521 pages
India Biosimilar Market Analysis
US$ 1,000.00
... 4 insulin biosimilars available in the Indian market. The acceptability of biosimilars is higher in the domestic market. Biosimilar substitution is automatic and can take place as soon as a biosimilar is launched. “India Biosimilar Market Analysis” research report by KuicK research gives detailed insight on various aspects related the biosimilar market in India like Market Overview, Biosimilar Pipeline Analysis, Biosimilar Development Capabilities ...
August 2012
80 pages
Stem Cell Research in India 2012
US$ 950.00
The report is sent in 0-2 business days after order is placed. The stem cell research in India is in its nascent stage and is gradually on a growth path of acceptance by ... covers the market size and growth prospect of the stem cell banking market in India. In addition to these, the report gives a snapshot of ...
July 2012
65 pages
Global Biosimilars Market Report: 2012 Edition
US$ 800.00
... lower return on investments continues to challenge the attractiveness of the biosimilars market. The report analyzes the global biosimilars market. The various drivers and challenges faced by the ...
June 2012
40 pages
Generic Testing Market Report: 2012 Edition
US$ 800.00
... to hinder the growth of the market in the coming years. The current report analyzes the genetic testing market. It discusses the drivers and ... challenges prevailing in the genetic testing market. It presents the ...
June 2012
45 pages
Rising Stars (Small-Mid Cap) Biotech/Biopharma: Investment Opportunities
US$ 400.00
... continue in 2012. In this report, we highlight the investment opportunities in the mid-small cap Rising Star companies: ARQL: Key Driver is Tivantinib (c-MET inhibitor) in PhIII for ... of the risk reward please read our report titled, “Rising Stars (Small-Mid Cap) Biotech/Biopharma: Investment Opportunities”.
June 2012
18 pages
The Chinese R&D Landscape - Biotechnology
US$ 1,200.00
R&D in China in the field of biotechnology* has surged over the last decade. This report seeks to answer the following questions related to this surge in R&D:
Where in China does the R&...
May 2012
12 pages
Global Biotech API Market Analysis
US$ 1,000.00
Biotech APIs contribute a very low share in the global API market with synthetic API’s accounting for majority of the formulations. However, with the revolutionary growth in the biopharmaceutical indu...
May 2012
60 pages
Biogen: Teriflunomide Does Not TOWER Over BG-12!
US$ 90.00
Top-line data from PhIII trial, TOWER of Sanofi’s Aubagio (teriflunomide, R, RRMS, PDUFA: 3Q12) reaffirms our take on BG-12 (Dimethyl fumerate, R, Est. ... details, please read our report released on June 1st , 2012 on Biogen (BIIB), titled “Teriflunomide Does Not TOWER Over BG-12”
May 2012
4 pages
Biotechnology in India: Market Research Report
US$ 3,950.00
This report analyzes the market for Biotechnology in India in US$ million by the following Key Sectors: Bio-Pharmaceuticals, Bio-Agriculture, Bio-Industrial, ... , Lambda Therapeutic Research Ltd., Mahyco, Max Neeman, Monsanto, Novo Nordisk India Pvt.Ltd., Novozymes South Asia Pvt.Ltd., Nuziveedu Seeds Pvt.Ltd., ...
April 2012
396 pages
